Chemin de navigation

Autres outils



    Profil de l'entité enregistrée

GlaxoSmithKline

Numéro d'identification dans le Registre : 7990322925-77
Date d'inscription : 06/01/2009 16:12:35

Les informations relatives à cette entité ont été modifiées en dernier lieu le: 15/06/2015 10:39:45
La dernière mise à jour annuelle date du: 27/04/2015 10:18:31
Date limite de la prochaine mise à jour: 27/04/2016

    Entité enregistrée : Organisation ou personne agissant en qualité d'indépendant

GlaxoSmithKline

GSK

Corporation

    Catégorie de l'enregistrement

II - «Représentants internes», groupements professionnels et associations syndicales et professionnelles

Sociétés & groupes

    Coordonnées

Great West Road, 980
TW8 9GS Brentford, Middlesex
ROYAUME-UNI

(+44) 20 8047 5000

Avenue des Arts 46/b9
1000 Brussels
BELGIQUE

(+32) 2 282 40 55

    Personne juridiquement responsable

Monsieur  Andrew Witty

Chief Executive Officer

    Personne chargée des relations avec l'UE

Madame  Sue Middleton

Vice President European Government Affairs

    Objectifs et missions

GSK is a science-led global healthcare company.

Our mission is to help people do more, feel better, live longer.


We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare that can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.

Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines and we have leading global positions in respiratory disease and HIV.

Our Vaccines business is one of the largest in the world. We have a broad portfolio of over 30 paediatric, adolescent, adult and travel vaccines. In 2014, we distributed approximately 800 million doses in 170 countries.

We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.


We have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.

mondial

    Activités spécifiques couvertes par le registre

We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.

This includes topics such as R&D and clinical trials, antimicrobial resistance, data protection, pharmaceutical legislation, medical devices, trade & IP, environment, smoking cessation.

Mainly via the participation of events organized by Trade Associations and Think-Tanks.


 

Non

Non

EC Expert Group on Rare-Diseases (on behalf of EuropaBio)

Non

Non

    Nombre de personnes participant aux activités décrites dans le champ ci-dessus

100%: 0   75%: 3   50%: 3   25%: 5

11

5

The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.

    Personnes accréditées pour accéder aux bâtiments du Parlement européen

Prénom Nom Date de début Date de fin
Sophie Renee Jeanne Marie Philippine Crousse 03/09/2014 28/08/2015
Christian Baracat 26/08/2014 19/08/2015
Paulus Lambertus Antonius van Hoof 02/08/2014 31/07/2015
Guilherme Monteiro Ferreira Borges Dos Santos 30/09/2014 26/09/2015
Gisela Payeras Bailly 26/08/2014 19/08/2015
Karin Jeanette Drielsma 06/08/2014 04/08/2015

    Domaines d'intérêt

  • Affaires économiques et financières
  • Affaires générales et institutionnelles
  • Aide humanitaire 
  • Commerce
  • Concurrence
  • Consommateurs
  • Douanes
  • Élargissement  
  • Emploi et affaires sociales  
  • Entreprises
  • Environnement  
  • Fiscalité
  • Marché intérieur 
  • Politique régionale  
  • Recherche et technologie   
  • Relations extérieures   
  • Santé publique   
  • Sécurité alimentaire 
  • Société de l'information    

    Composition et affiliation

American Chamber of Commerce to the European Union (AmChamEU)
Association of the European Self-Medication Industry (AESGP)
British Chamber of Commerce in Belgium
Cosmetics Europe
EuropaBio
European Biopharmaceutical Enterprises (EBE)
European Brands Association (AIM)
European Diagnostic Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
World Federation of Advertisers (WFA)

    Données financières

01/2014  -  12/2014

>= 1 750 000 € et < 1 999 999 €

0 €

N/A

10 445 466 €

FP7-People; FP7-NMP; Horizon 2020

In 2013, GSK’s estimated costs attributable to activities covered by the Register were in the range of 600.000-700.000. While GSK maintained activities in scope of the register from 2013 to 2014, the increased figures result from vacancies and the renewed “transparency register implementing guidelines” published 21 January 2015 by the Joint Transparency Register Secretariat.
GSK followed EFPIA’s interpretation and guidance on implementing those guidelines in 2014.

    Code de conduite

En s'enregistrant, l'organisation a signé le code de conduite du registre de transparence.